BID | 40.96 | ASK | 163.82 | ||
Open | 99.45 | Previous Close | 99.71 | ||
Pre-Market | - | After-Market | 102.95 | ||
- - | - -% |
Target Price | 122.71 | Analyst Rating | Strong Buy 1.25 | |
Potential % | 19.19 | Finscreener Ranking | ★★★+ 51.60 | |
Insiders Trans % 3/6/12 mo. | -100/-100/-100 | Value Ranking | ★★★+ 53.96 | |
Insiders Value % 3/6/12 mo. | -100/-100/-100 | Growth Ranking | ★★★★ 57.65 | |
Insiders Shares Cnt. % 3/6/12 mo. | -100/-100/-100 | Income Ranking | — - | |
Price Range Ratio 52W % | 70.87 | Earnings Rating | Sell | |
Market Cap | 1.66B | Earnings Date | 1st May 2023 | |
Alpha | 0.01 | Standard Deviation | 0.10 | |
Beta | 0.83 |
Today's Price Range 98.70103.02 | 52W Range 73.66114.99 | 5 Year PE Ratio Range 24.4075.60 |
Summary:
Neutral
Technical Indicators: | Neutral |
Moving Averages: | Buy |
Performance | |||
---|---|---|---|
1 Week | 5.12% | ||
1 Month | -1.57% | ||
3 Months | 1.97% | ||
6 Months | 15.22% | ||
1 Year | 22.43% | ||
3 Years | 65.04% | ||
5 Years | 126.51% | ||
10 Years | 782.93% |
Mngmt Effectiveness | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
ROE (5Y Avg) | 5.74 | |||
ROE last 12 Months | 8.15 | |||
ROA (5Y Avg) | 2.18 | |||
ROA last 12 Months | 5.13 | |||
ROC (5Y Avg) | 5.81 | |||
ROC last 12 Months | 6.06 | |||
Return on invested Capital Q | 1.62 | |||
Return on invested Capital Y | 1.71 | |||
Assets Turnover | 0.80 | |||
Receivables Turnover | 5.60 |
Valuation | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
36.90 | ||||
2.66 | ||||
2.30 | ||||
15.40 | ||||
-249.80 | ||||
6.57 | ||||
-49.44 | ||||
38.16 | ||||
1.74B | ||||
Forward PE | 27.90 | |||
PEG | 3.27 |
Financial Strength | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
1.80 | ||||
1.90 | ||||
0.25 | ||||
0.33 | ||||
8.70 | ||||
Leverage Ratio | 1.60 |
Profitability | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
31.60 | ||||
7.30 | ||||
8.80 | ||||
5.60 | ||||
4.44 |
Revenue | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
704.07M | ||||
43.70 | ||||
14.86 | ||||
17.22 |
Dividends | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
- | ||||
- | ||||
- | ||||
- | ||||
Payout ratio | - |
Earnings History | Estimate | Reported | Surprise % |
---|---|---|---|
Q04 2022 | 0.85 | 0.98 | 15.29 |
Q03 2022 | 0.81 | 0.80 | -1.23 |
Q02 2022 | 0.79 | 0.79 | 0.00 |
Q01 2022 | 0.67 | 0.66 | -1.49 |
Q04 2021 | 0.87 | 0.86 | -1.15 |
Q03 2021 | 0.82 | 0.80 | -2.44 |
Q02 2021 | 0.80 | 0.78 | -2.50 |
Q01 2021 | 0.64 | 0.62 | -3.12 |
Earnings Per End | Estimate | Revision % | Trend |
---|---|---|---|
12/2022 QR | 0.86 | -1.15 | Negative |
12/2022 FY | 3.12 | -0.32 | Negative |
3/2023 QR | 0.77 | -10.47 | Negative |
12/2023 FY | 3.51 | -3.57 | Negative |
Next Report Date | 1st May 2023 |
Estimated EPS Next Report | 0.81 |
Estimates Count | 4 |
EPS Growth Next 5 Years % | 11.30 |
Volume Overview | |
---|---|
Volume | 73.52K |
Shares Outstanding | 16.13K |
Shares Float | 13.12M |
Trades Count | 3.05K |
Dollar Volume | 7.51M |
Avg. Volume | 118.02K |
Avg. Weekly Volume | 142.06K |
Avg. Monthly Volume | 123.15K |
Avg. Quarterly Volume | 88.87K |
Addus HomeCare Corporation (NASDAQ: ADUS) stock closed at 102.95 per share at the end of the most recent trading day (a 3.25% change compared to the prior day closing price) with a volume of 73.52K shares and market capitalization of 1.66B. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Healthcare Providers & Services industry, Healthcare sector and employs 33238 people. Addus HomeCare Corporation CEO is R. Dirk Allison.
The one-year performance of Addus HomeCare Corporation stock is 22.43%, while year-to-date (YTD) performance is 3.48%. ADUS stock has a five-year performance of 126.51%. Its 52-week range is between 73.655 and 114.99, which gives ADUS stock a 52-week price range ratio of 70.87%
Addus HomeCare Corporation currently has a PE ratio of 36.90, a price-to-book (PB) ratio of 2.66, a price-to-sale (PS) ratio of 2.30, a price to cashflow ratio of 15.40, a PEG ratio of 2.32, a ROA of 5.13%, a ROC of 6.06% and a ROE of 8.15%. The company’s profit margin is 4.44%, its EBITDA margin is 8.80%, and its revenue ttm is $704.07 Million , which makes it $43.70 revenue per share.
Of the last four earnings reports from Addus HomeCare Corporation, there were 1 positive earnings surprise and 2 negative earnings surprise. The company has EPS estimate of $0.81 for the next earnings report. Addus HomeCare Corporation’s next earnings report date is 01st May 2023.
The consensus rating of Wall Street analysts for Addus HomeCare Corporation is Strong Buy (1.25), with a target price of $122.71, which is +19.19% compared to the current price. The earnings rating for Addus HomeCare Corporation stock is Sell (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).
Addus HomeCare Corporation has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.
Addus HomeCare Corporation has a Neutral technical analysis rating based on Technical Indicators (ADX : 15.41, ATR14 : 3.03, CCI20 : -13.10, Chaikin Money Flow : -0.07, MACD : -1.44, Money Flow Index : 27.02, ROC : -0.01, RSI : 51.83, STOCH (14,3) : 77.97, STOCH RSI : 1.00, UO : 55.39, Williams %R : -22.03), Simple Moving Averages and Exponential Moving Averages.
Aggregated Insider Trades of Addus HomeCare Corporation in the last 12-months were: Brian Poff (Sold 9 785 shares of value $948 271 ), Darby Anderson (Option Excercise at a value of $133 650), Darby Anderson (Sold 17 682 shares of value $1 780 797 ), David W. Tucker (Sold 8 861 shares of value $876 178 ), Esteban Lopez (Sold 1 100 shares of value $104 500 ), Michael D. Wattenbarger (Option Excercise at a value of $19 688), Michael D. Wattenbarger (Sold 4 208 shares of value $401 859 ), Monica Raines (Sold 587 shares of value $62 176 ), R. Dirk Allison (Option Excercise at a value of $492 750), R. Dirk Allison (Sold 65 068 shares of value $6 824 751 ), Robertson James Stevenson (Sold 605 shares of value $58 177 ), Sean Gaffney (Option Excercise at a value of $1 377 800), Sean Gaffney (Sold 20 601 shares of value $2 090 979 ), W. Bradley Bickham (Option Excercise at a value of $518 250), W. Bradley Bickham (Sold 38 331 shares of value $3 831 127 )
Analyst Ratings | Current | 1 M ago | 3 M ago |
---|---|---|---|
Strong Buy | |||
Moderate Buy | |||
Hold | |||
Moderate Sell | |||
Strong Sell | |||
Summary Rating | Strong Buy | Strong Buy | Strong Buy |
Addus HomeCare Corp is engaged in the provision of in-home personal care services. It operates through the following segments: Personal care segment which provides non-medical assistance with activities of daily living, primarily to persons who are at risk of hospitalization or institutionalization, such as the elderly, chronically ill and disabled. Its Hospice segment provides physical, emotional and spiritual care for people who are terminally ill and their families. Its Home health segment provides services that are primarily medical in nature to those individuals who may require assistance during an illness or after surgery.
CEO: R. Dirk Allison
Telephone: +1 469 535-8200
Address: 6303 Cowboys Way, Frisco 75034, TX, US
Number of employees: 33 238
Mon, 06 Mar 2023 16:30 GMT Analysts Offer Insights on Healthcare Companies: Addus Homecare (ADUS), Gilead Sciences (GILD) and Surgery Partners (SGRY)
- TipRanks. All rights reserved.Copyright © 2016-2023 Finscreener.org. All Rights Reserved.
Disclaimer: Before deciding to trade you should carefully consider your investment objectives, level of experience and your risk appetite. Forex and Tradegate data is a real-time with a 30 second refresh. Prices may not be accurate and may differ from the actual market price. Prices on the website are indicative and solely for informational purposes, not for trading purposes or advice. Please be aware of the risks associated with trading the on financial markets, it is one of the riskiest investment forms. Past performance does not guarantee future profits. We take no responsibility for any losses that may arise as a result of the data contained on this website. The content and the website are provided "as is", without any warranties. In no event will Finscreener.org, its employees, owners, directors, affiliates, partners, data provider, third party or anyone else liable to anyone else for any decision made regarding information on this website.
All rights reserved. Financial Market Data powered by Quotemedia.com. All rights reserved. View the Terms of Use. NYSE/NYSE MKT (AMEX) data delayed 20 minutes. NASDAQ and other data delayed 15 minutes unless otherwise indicated. Copyright © 2023. All market data is provided by Quotemedia.com. Futures: at least a 10 minute delay. Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. To see all exchange delays and terms of use, please see disclaimer. The Cryptocurrency Market real-time data provided by Cryptocompare.com
General partner of Finscreener is SLOVAKODATA, a.s.
Don´t have an account? Register
Looks like you are using AdBlock.
The revenue earned from advertising enables us to provide the quality content you are trying to reach on this website. In order to view this page, please disable AdBlock or purchase Premium.
Sign in if you already have Premium account.
This could take some time, please wait.